AVITA Medical, Inc. - Common Stock (RCEL) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
RCEL on Nasdaq
Shares outstanding
30,540,782
Price per share
$4.36
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
4,822,753
Total reported value
$16,637,912
% of total 13F portfolios
0%
Share change
-305,436
Value change
-$1,612,081
Number of holders
67
Price from insider filings
$4.36
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AVITA Medical, Inc. - Common Stock (RCEL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 4.7% $4,988,131 1,444,579 The Vanguard Group 31 Dec 2025
BlackRock, Inc. 4.3% $5,816,042 1,138,436 BlackRock, Inc. 30 Sep 2025

As of 31 Dec 2025, 67 institutional investors reported holding 4,822,753 shares of AVITA Medical, Inc. - Common Stock (RCEL). This represents 16% of the company’s total 30,540,782 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of AVITA Medical, Inc. - Common Stock (RCEL) together control 15% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 4.7% 1,444,579 +5.8% 0% $4,983,797
BlackRock, Inc. 3.5% 1,079,699 -5.2% 0% $3,724,961
GEODE CAPITAL MANAGEMENT, LLC 1.6% 479,185 +45% 0% $1,653,642
STATE STREET CORP 1.4% 418,331 -1.2% 0% $1,443,242
NORTHERN TRUST CORP 0.54% 163,403 -5.4% 0% $563,740
MORGAN STANLEY 0.49% 149,715 +54% 0% $516,517
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.39% 118,004 0% 0.01% $407,114
AQR CAPITAL MANAGEMENT LLC 0.33% 101,492 -15% 0% $350,148
Divisadero Street Capital Management, LP 0.33% 100,000 0% 0.02% $345,000
UBS Group AG 0.3% 90,309 +20% 0% $311,566
GOLDMAN SACHS GROUP INC 0.26% 80,613 -31% 0% $278,115
STRS OHIO 0.16% 47,700 0% 0% $164,565
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.15% 46,255 +1.4% 0% $159,580
Nuveen, LLC 0.14% 41,962 0% 0% $144,769
MILLENNIUM MANAGEMENT LLC 0.13% 38,498 -71% 0% $132,818
Bank of New York Mellon Corp 0.1% 29,862 -3.6% 0% $103,023
AMERIPRISE FINANCIAL INC 0.1% 29,122 +0.17% 0% $100,471
RHUMBLINE ADVISERS 0.09% 27,833 -27% 0% $96,015
GABELLI FUNDS LLC 0.09% 26,500 -24% 0% $91,425
BANK OF AMERICA CORP /DE/ 0.08% 25,329 -59% 0% $87,384
IHT Wealth Management, LLC 0.08% 25,100 -2.9% 0% $86,596
Jain Global LLC 0.08% 24,168 0% $83,380
ALLIANCEBERNSTEIN L.P. 0.07% 20,250 0% 0% $69,863
CITADEL ADVISORS LLC 0.07% 20,190 0% $69,656
BARCLAYS PLC 0.06% 19,075 -2.8% 0% $65,808

Institutional Holders of AVITA Medical, Inc. - Common Stock (RCEL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 4,822,753 $16,637,912 -$1,612,081 $3.45 67
2025 Q3 5,138,582 $26,258,249 -$13,168,452 $5.11 75
2025 Q2 7,684,503 $40,650,943 +$2,876,263 $5.29 79
2025 Q1 7,044,428 $57,343,339 +$2,375,906 $8.14 74
2024 Q4 6,454,868 $82,623,830 +$4,559,187 $12.80 72
2024 Q3 6,095,789 $65,347,676 +$515,283 $10.72 67
2024 Q2 6,099,329 $48,306,700 -$15,647,217 $7.92 68
2024 Q1 7,319,846 $117,332,190 +$4,381,511 $16.03 81
2023 Q4 7,095,304 $97,348,681 -$14,976,745 $13.72 83
2023 Q3 8,129,935 $118,780,112 +$7,346,625 $14.61 80
2023 Q2 7,611,611 $129,472,974 +$30,265,942 $17.01 80
2023 Q1 5,906,388 $82,511,505 +$21,157,921 $13.97 72
2022 Q4 4,410,243 $29,107,642 +$1,258,474 $6.60 51
2022 Q3 4,306,669 $22,694,330 -$3,509,090 $5.27 42
2022 Q2 5,060,740 $24,039,067 -$9,600,413 $4.75 48
2022 Q1 6,867,607 $58,179,804 -$8,054,352 $8.48 65
2021 Q4 7,465,802 $89,556,714 -$12,879,940 $11.98 59
2021 Q3 8,337,406 $148,034,944 -$7,922,344 $17.72 67
2021 Q2 8,754,978 $179,543,764 +$37,847,379 $20.52 69
2021 Q1 7,070,182 $139,896,335 +$55,735,706 $19.82 59
2020 Q4 4,168,156 $77,440,780 +$11,413,265 $18.58 49
2020 Q3 3,433,525 $86,331,057 +$50,603,668 $25.16 40
2020 Q2 1,409,579 $43,046,283 +$43,046,283 $30.53 31
2020 Q1 300 $6,000 $20.00 1
2019 Q4 300 $6,000 $20.00 1
2019 Q3 300 $6,000 $20.00 1
2019 Q2 300 $6,000 $20.00 1
2019 Q1 300 $6,000 $20.00 1